inclusion criteria: * female subjects of childbearing potential must have a negative serum pregnancy test result at screening and a negative urine pregnancy test result prior to dosing. * female subjects of childbearing potential and male subjects with a female partner of childbearing potential must use an effective method of contraception during the study, for at least 1 month following study completion, and must not plan to become pregnant for at least 1 month after her last study medication dose. * bmi 18-32 kg/m2 inclusive * ability to understand and provide informed consent * subjects confirmed with sars-cov-2 infection by pcr and hospitalized * if on mechanical support, less or equal than 2 days on mechanical ventilation or oxygenation

inclusion criteria: * female subjects of childbearing potential must have a negative serum pregnancy test result at screening and a negative urine pregnancy test result prior to dosing. * female subjects of childbearing potential and male subjects with a female partner of childbearing potential must use an effective method of contraception during the study, for at least 1 month following study completion, and must not plan to become pregnant for at least 1 month after her last study medication dose. * bmi 18-32 kg/m2 inclusive * ability to understand and provide informed consent * subjects confirmed with sars-cov-2 infection by pcr and hospitalized * if on mechanical support, less or equal than 2 days on mechanical ventilation or oxygenation

inclusion criteria: - female subjects of childbearing potential must have a negative serum pregnancy test result at screening and a negative urine pregnancy test result prior to dosing. - female subjects of childbearing potential and male subjects with a female partner of childbearing potential must use an effective method of contraception during the study, for at least 1 month following study completion, and must not plan to become pregnant for at least 1 month after her last study medication dose. - bmi 18-32 kg/m2 inclusive - ability to understand and provide informed consent - subjects confirmed with sars-cov-2 infection by pcr and hospitalized - if on mechanical support, less or equal than 2 days on mechanical ventilation or oxygenation

inclusion criteria: - female subjects of childbearing potential must have a negative serum pregnancy test result at screening and a negative urine pregnancy test result prior to dosing. - female subjects of childbearing potential and male subjects with a female partner of childbearing potential must use an effective method of contraception during the study, for at least 1 month following study completion, and must not plan to become pregnant for at least 1 month after her last study medication dose. - bmi 18-32 kg/m2 inclusive - ability to understand and provide informed consent - subjects confirmed with sars-cov-2 infection by pcr and hospitalized - if on mechanical support, less or equal than 2 days on mechanical ventilation or oxygenation